INTRODUCTION
The myxoviruses which infect man can be divided into two major subgroups (Table 1) : the influenza subgroup which includes influenza virus types A, B, and C and the noninfluenza subgroup which includes parainfluenza types 1 (HA-2), 2 (CA), 3 (HA-1), and 4, mumps, measles, and respiratory syncytial viruses.
Related but distinct antigenic variants or subtypes have been detected among types of both subgroups. In this manner, three subtypes are included among influenza virus type A: A, Al, and A2 (16, 17, 18) . Influenza virus type B comprises three subtypes: B, B1, and B2 (16, 17, 23) . Recently, two subtypes, A and B, were recognized for parainfluenza type 4 virus (4). In addition, at least two different antigenic variants have been detected among respiratory syncytial virus strains (7) . BIOPHYSICAL AND BIOLOGICAL PROPERTIES OF HUMAN MYXOVIRUSES As determined by electron microscopy, with the use of the phosphotungstic acid-negative staining technique, human myxoviruses are medium-sized, that is, they measure from 80 to 120 mAu (influenza subgroup) or from 150 to 250 m,4 1 Presented at the Annual Meeting of the American Society for Microbiology, Washington, D.C., 6 May 1964. (noninfluenza subgroup) (29) . These viruses contain ribonucleic acid (RNA). The nucleoprotein or inner component possesses a helical symmetry and is surrounded by an outer envelope of lipoprotein with periodic projections which represent the hemagglutinin. The ribonucleoprotein helix of the parainfluenza viruses appears to be single-stranded (6) .
Myxoviruses are inactivated by diethyl ether and by a low pH (i.e., 3.0 or less) (1, 14) . They are also rapidly inactivated at temperatures between 20 and 37 C. Most types hemagglutinate and hemadsorb avian and/or mammalian erythrocytes, the exception being respiratory syncytial virus. They exhibit variable cytopathology during replication in tissue culture, ranging from minimal cell degeneration (as with parainfluenza types 1 and 4 virus) to marked syncytial formation (as with measles and respiratory syncytial viruses).
ISOLATION OF HUMAN MYXOVIRUSES
For successful isolation of these viruses, adequate collection and handling of clinical specimens is of the utmost importance.
Because of the instability of most myxoviruses, specimens should be collected in media containing protein stabilizers, i.e., bovine albumin or gelatin, and adjusted to pH 7.2. In addition, specimens should be inoculated into susceptible The occurrence of the hemadsorption phenomenon is accounted for by certain factors involved in the replication of myxoviruses. Assembly or maturation of the infectious virus particle takes place at or near to the host-cell surface, and its release is carried out over a long period of time by a process of extrusion or by filament formation (22) . Thus, the virus outercoat material is present at the host-cell surface, providing sites to which the erythrocytes can adsorb.
These characteristics make the hemadsorption phenomenon a reliable indicator system for detection of myxovirus strains in susceptible tissue culture systems. Consequently, it is a fundamental technique for the recognition of naturally occurring strains of parainfluenza viruses.
The use of primary monkey kidney culture combined with hemadsorption for isolationpassage of hemadsorbing myxoviruses provides certain advantages over the use of embryonated eggs. Monkey kidney cultures are readily available, are easily manipulated, and can be held in incubation for at least 4 weeks; embryonated eggs must be inoculated when they are of a certain age and cannot be held after 3 weeks of incubation. In addition, tissue culture favors the replication of some human myxoviruses which grow poorly, or not at all, in eggs, such as parainfluenza virus types 1, 2, 3, and 4, and respiratory syncytial virus.
Conflicting results have been reported concerning the sensitivity of monkey kidney cultures for recovery of influenza A2 strains (19, 20, 21, 24) . Even though we have not compared the sensitivity of embryonated eggs and monkey kidney tissue culture for primary isolation of influenza A2 strains, our experience suggests that monkey kidney is an efficient system for recovery of these strains. Several comparative studies have indicated that monkey renal tissue culture is superior to eggs for recovery of influenza B viruses (13, 26) .
The use of monkey kidney tissue culture in myxovirus isolation attempts, however, does involve a serious problem, and that is the frequent occurrence of two simian myxoviruses, SV5 and SV41, as indigenous contaminants of the cell culture system (5, 20a) . Both simian myxoviruses share antigenic components with the prototype human parainfluenza 2 virus (CA) when tested by complement fixation (5, 20a) . However, they are distinct among themselves and from the prototype human parainfluenza 2 virus (CA) when tested by tissue culture neutralization or hemadsorption inhibition with specific guinea pig sera (5) . This disadvantage, however, should not preclude the use of monkey kidney tissue culture for isolation of human myxoviruses. Contamination by these simian agents, most often by SV5, can be controlled by adding 0.2% of hyperimmune rabbit serum to both growth and maintenance media of monkey kidney cultures. Although the growth of human parainfluenza type 2 virus (CA) is not inhibited by this concentration of anti-SV5 rabbit serum, there is cause for concern. Recently, evidence has been presented that SV5
can infect man (15) . In addition, there may exist as yet undetected human myxoviruses which share major antigenic components with VOL. 29, 1965 these simian agents. If so, they will not be recovered in cultures containing simian virus immune serum. Furthermore, during isolation passage avid strains of influenza A2 virus are frequently nonspecifically inhibited by mucoproteins contained in the anti-SV5 rabbit serum used in the maintenance media. Tissue cultures inoculated with specimens from individuals with illness are tested for hemadsorption at 5-day incubation intervals from 3 to 4 weeks, depending on the appearance and viability of the tissue culture cell monolayer. The quantity of free virus in the fluid medium is usually insufficient to interfere with the hemadsorption reaction.
HEMADSORPTION TECHNIQUE
During subsequent passage of the isolates, however, higher concentrations of free virus, sufficient to interfere with hemadsorption, are found in the fluid medium 3 to 5 days after subinoculation of the tissue cultures. Because of the formation of large aggregates of agglutinated erythrocytes in the medium, few such cells are available for hemadsorption. It is advisable, when large quantities of virus have been inoculated, to wash the cultures three times before attempting to test for hemadsorption. It is also desirable to use fresh or recently harvested guinea pig erythrocytes, since older cells often produce nonspecific hemadsorption patterns.
The time required for initial detection of human myxoviruses in primary rhesus monkey kidney by hemadsorption with guinea pig erythrocytes is shown in Table 2 . In a 5-year period, 94 % of 745 isolates were detected by hemadsorption within 2 weeks after inoculation of the cultures with throat-swab specimens. The majority of influenza virus types A2 and B and parainfluenza virus types 1 and 3 isolates were detected within 10 days, and mumps virus isolates were detected within 15 days after inoculation of the cultures. Parainfluenza virus (27) .
IDENTIFICATION OF HUMAN MYXOVIRUS ISOLATES Preparation of Specific Immune Sera
The preparation of specific immune sera for human myxoviruses deserves special consideration. Among the most common laboratory animals, guinea pigs, hamsters, and ferrets are susceptible to infection by human myxoviruses when inoculated by the intranasal route (8, 9, 10, 11, 12). Although rabbits and roosters are insensitive to infection, they can be used for preparation of myxovirus antisera. However, heterologous antibody responses may occur in these animals after repeated booster inoculations.
Animals used for preparation of immune sera should come from colonies kept in isolation and cared for by only one individual. In addition, they should be free from antibodies for known myxoviruses. Certain colonies of guinea pigs are found to have antibodies against human parainfluenza type 3 (HA-1) and less often against human parainfluenza types 1 or 2 or mumps virus.
After intranasal inoculation, the infected 
Mumps, rev/min for 1 hr in the model L Spinco ultracentrifuge. Table 6 shows the specificity of the complement fixation test for differentiation of parainfluenza virus serotypes. Results presented in the table indicate the lack of relationship among parainfluenza types 1, 2, 3, and 4 viruses. However, parainfluenza 4 subtypes A and B are closely related when tested by complement fixation.
If, after exhausting all of these serological techniques, the hemadsorbing isolate still remains unidentified, it is likely that such an isolate may well represent a new antigenic variant or subtype. In these cases, specific antiserum against the isolate can be prepared by intranasal inoculation of guinea pigs or hamsters free from antibodies for known human myxoviruses. As soon as the specific immune serum is available, the unidentified strain must be fully characterized and cross-tested by tissue culture neutralization,hemadsorption-inhibition, and complement fixation against the known human myxovirus prototypes. This characterization is required to determine the extent and nature of the antigenic differences.
Identification of Nonhemadsorbing
Myxovirus Isolates Respiratory syncytial virus strains are routinely identified by complement fixation. After the isolation passage, the isolates are subinoculated into HEp-2 cell cultures and complementfixing antigens are prepared from infected culture suspensions. Specific antiserum for respiratory syncytial virus can be produced by intranasal infection of ferrets (8) Because of these failures, the isolates were subsequently examined by complement fixation. As shown in Table 7 , these isolates reacted only with the specific guinea pig serum prepared against the parainfluenza type 4 virus (M-25 strain). Further complement fixation tests definitively established that these new strains were antigenically identical, and indistinguishable from the prototype strain.
However, the earlier results obtained by hemadsorption-inhibition suggested the possibility of antigenic differences between them. Therefore, evidence of specific antigenic differences was sought and demonstrated by tissue culture neutralization (Table 8 ). Only two isolates were identical to the prototype strain, whereas the remaining isolates were found related but distinct from it.
A more complete characterization of all the 1962 and 1963 strains was carried out by hemadsorption inhibition with the use of specific guinea pig sera pools, as summarized in Table 9 . Results permitted the segregation of all of the isolates into two subtypes, according to their external antigenic structure; subtype A, containing strains indistinguishable from the prototype virus, and subtype B, containing those strains related but distinct from the prototype strain (4).
It is not known whether both subtypes have existed for a long time or whether this antigenic variation is discontinuous in nature, as is the case with influenza A and B viruses.
Other human myxoviruses. Influenza C, parainfluenza types 1, 2, and 3, mumps, and measles viruses appear to be antigenically stable and homogenous. Thus far, antigenic variation of these myxovirus serotypes has not been detected.
